RESOMER
LIVE

Serial Number

79129166

Owner

Evonik Industries AG

Attorney

Scott D. Woldow

Filing Date

Feb 19, 2013

Add to watchlist:

No watchlists yet
View on USPTO

RESOMER Trademark

Serial Number: 79129166 • Registration: 4508630

RESOMER is a trademark filed by Evonik Industries AG on February 19, 2013. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Evonik Industries AG (72 trademarks)

Rellinghauser Str. 1 - 11

Entity Type: 99

EVONIK OPERATIONS GMBH (467 trademarks)

RELLINGHAUSER STRASSE 1-11
ESSEN 45128 , DE

Entity Type: 16

Evonik Röhm GmbH (27 trademarks)

Kirschenallee

Entity Type: 98

Trademark Details

Filing Date

February 19, 2013

Registration Date

April 8, 2014

Published for Opposition

January 21, 2014

Goods & Services

Chemicals used in industry, science [ and photography ], as well as in agriculture, horticulture and forestry except fungicides, herbicides, and parasiticides; Chemicals for use in industry, namely, chemicals for use in cosmetic products; Chemicals for use in the pharmaceutical industry; Chemicals for use in the cosmetic industry; Chemicals for use in industry, namely, polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Chemicals for use in industry, namely, polymer-based edible coatings for tablets; Chemicals for use in industry, namely, unprocessed polymers;unprocessed artificial resins, unprocessed plastics, artificial resins in the form of powders, granules, solutions, emulsions, dispersions, and pastes, in particular for use as auxiliaries for the manufacture of pharmaceutical products, biodegradable polymers for medical and pharmaceutical use [ ; chemical substances for preserving foodstuffs; adhesives used in industry ]

[ Surgical, medical, dental and veterinary apparatus and instruments, namely, implantable ports; Surgical, medical, dental and veterinary apparatus and instruments, namely, drug delivery systems; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; Bone implants composed of artificial materials; Fixation implants comprised of artificial material; Implants consisting of artificial materials; Medical and surgical apparatus and instruments, namely, orthopedic fixation device used in orthopedic transplant and/or implant surgery; Medical and surgical apparatus and instruments, namely, devices used in orthopedic surgery to position surgical instruments, implants and/or patients' limbs; Medical devices, namely, intravascular implants comprised of artificial material; Medical, surgical and orthopaedic implants made of artificial materials; Orthopedic joint implants made of artificial materials; Surgical implants and mesh made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Surgical implants comprising artificial material; Medical devices and apparatus, namely, surgical implants comprised primarily of artificial material for use in plastic reconstructive surgery, and repair, reinforcement or buttressing of soft tissue, and parts and fittings therefor; Implantable scaffolds comprising artificial materials for maintaining tissue contour; Prosthetic tissues for parietal, visceral and vascular use; Synthetic media for use in the augmentation of bone and tissue for medical purposes; artificial limbs, eyes and teeth; orthopaedic articles, namely, medical apparatus and instruments for use in orthopedic surgery; Medical instruments, namely, orthopedic apparatus and instruments; Surgical and medical apparatus and instruments for use in orthopedic surgery; Suture materials ]

[ Pharmaceutical and veterinary preparations, namely, drug delivery agents in the form of a coating for tablets, powders and capsules that facilitate the delivery of a wide range of pharmaceuticals; lacquers and glazes for pharmaceutical and veterinary preparations, namely, conductive lacquer for dental purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for medical and hygienic purposes, namely, chemical preparations for sanitary purposes; sanitary preparations for medical purposes; functional food for medical purposes, namely, nutraceuticals for use as a dietary supplement; all-purpose disinfectants ]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 21, 2026 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 21, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
May 21, 2025 71.P
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 21, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
May 21, 2025 71.P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 19, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC.71
Nov 20, 2024 PR71
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 18, 2024 APRE
TEAS SECTION 71 RECEIVED
Apr 8, 2024 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Apr 8, 2023 REM4
INTERNATIONAL REGISTRATION RENEWED
Mar 17, 2023 RNWL
CHANGE OF OWNER RECEIVED FROM IB
Jul 30, 2020 CHLD
PARTIAL INVALIDATION PROCESSED BY THE IB
Mar 6, 2020 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jan 29, 2020 INPS
INVALIDATION PROCESSED
Jan 29, 2020 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 8, 2020 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 8, 2019 NA71
REGISTERED-SEC.71 ACCEPTED
May 8, 2019 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 7, 2019 APRE
TEAS SECTION 71 RECEIVED
Apr 26, 2019 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 8, 2019 REM3
CHANGE OF OWNER RECEIVED FROM IB
Oct 15, 2015 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 31, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 16, 2014 FICS
FINAL DISPOSITION PROCESSED
Jul 16, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 8, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 8, 2014 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 21, 2014 NPUB
PUBLISHED FOR OPPOSITION
Jan 21, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Jan 16, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 1, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 1, 2014 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 19, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 18, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 18, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 18, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 18, 2013 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 9, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2013 CRFA
ASSIGNED TO LIE
Dec 2, 2013 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 21, 2013 TROA
REFUSAL PROCESSED BY IB
Jul 1, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 11, 2013 RFCS
REFUSAL PROCESSED BY MPU
Jun 11, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2013 RFCR
NON-FINAL ACTION WRITTEN
Jun 10, 2013 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2013 DOCK
APPLICATION FILING RECEIPT MAILED
May 14, 2013 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 9, 2013 REPR